JP Morgan Chase’s T2 Biosystems, Inc TTOO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-33
| Closed | -$14 | – | 7892 |
|
|
2024
Q4 | $14 | Buy |
+33
| New | +$28 | ﹤0.01% | 7301 |
|
|
2024
Q3 | – | Sell |
-15
| Closed | -$80 | – | 7843 |
|
|
2024
Q2 | $80 | Buy |
+15
| New | +$63 | ﹤0.01% | 6935 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 7353 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 7134 |
|
|
2022
Q1 | – | Sell |
-4
| Closed | -$9K | – | 7130 |
|
|
2021
Q4 | $9K | Sell |
4
-7
| -64% | -$24.3K | ﹤0.01% | 6357 |
|
|
2021
Q3 | $50K | Buy |
+11
| New | +$55.4K | ﹤0.01% | 5844 |
|
|
2020
Q4 | – | Sell |
-3
| Closed | -$19K | – | 6016 |
|
|
2020
Q3 | $19K | Buy |
+3
| New | +$22.2K | ﹤0.01% | 5161 |
|
|
2019
Q4 | – | Hold |
0
| – | -$5K | – | 5948 |
|
|
2019
Q3 | – | Sell |
-146
| Closed | -$1.17M | – | 5573 |
|
|
2019
Q2 | $1.15M | Buy |
146
+144
| +7,200% | +$1.69M | ﹤0.01% | 3769 |
|
|
2019
Q1 | $25K | Sell |
2
-20
| -91% | -$340K | ﹤0.01% | 5352 |
|
|
2018
Q4 | $328K | Sell |
22
-28
| -56% | -$658K | ﹤0.01% | 4348 |
|
|
2018
Q3 | $1.87M | Sell |
50
-73
| -59% | -$2.4M | ﹤0.01% | 3507 |
|
|
2018
Q2 | $4.75M | Buy |
123
+96
| +356% | +$3.64M | ﹤0.01% | 2721 |
|
|
2018
Q1 | $891K | Buy |
+27
| New | +$727K | ﹤0.01% | 3737 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 5297 |
|
|
2016
Q3 | – | Sell |
-1
| Closed | -$20K | – | 4873 |
|
|
2016
Q2 | $20K | Hold |
1
| – | – | ﹤0.01% | 4227 |
|
|
2016
Q1 | $30K | Buy |
+1
| New | +$44.2K | ﹤0.01% | 4010 |
|
JP Morgan Chase's TTOO Position: Q1 2025 in Review
JP Morgan Chase sold out of T2 Biosystems, Inc (TTOO) in Q1 2025, closing a stake of 33 shares — an estimated $14 sold.
JP Morgan Chase first reported a position in TTOO in Q1 2016 and held it in 13 quarters. The position peaked at $4.75M in Q2 2018. 2 funds tracked by Wall St. Rank hold TTOO as of Q1 2025.
- JP Morgan Chase reported no remaining T2 Biosystems, Inc position as of Q1 2025 after selling out during the quarter.
- JP Morgan Chase sold 33 T2 Biosystems, Inc shares in Q1 2025, an estimated $14.
- JP Morgan Chase first reported a position in T2 Biosystems, Inc in Q1 2016 and held it in 13 quarters.
- JP Morgan Chase's T2 Biosystems, Inc position peaked at $4.75M in Q2 2018.
- 2 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q1 2025.
Based on JP Morgan Chase's 13F filing for Q1 2025, filed 12 May 2025.